Biodelivery Sciences International reported $53.41M in Current Liabilities for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acelrx Pharmaceuticals ACRX:US $ 16.56M 0.13M
Adamas Pharmaceuticals ADMS:US $ 34.87M 3.38M
Adamis Pharmaceuticals ADMP:US $ 12.98M 0.61M
Alimera Sciences ALIM:US $ 12.35M 2.11M
Biocryst Pharmaceuticals BCRX:US $ 105.65M 6.12M
Biodelivery Sciences International BDSI:US $ 53.41M 3.24M
Cara Therapeutics CARA:US $ 18.48M 1.88M
Cti Biopharma CTIC:US $ 14.52M 0.77M
Daiichi Sankyo 4568:JP Y 313298M 16660M
Depomed DEPO:US $ 131.37M 3M
Endo International Ordinary Shares ENDP:US $ 1253.82M 37.17M
JAZZ PHA JAZZ:US $ 653.74M 11.61M
Johnson & Johnson JNJ:US $ 42493M 3646M
Knight Therapeutics Inc GUD:CN C$ 99.03M 212.96M
Lannett LCI:US $ 163.67M 55.53M
Mannkind MNKD:US $ 73.7M 32.42M
Nektar Therapeutics NKTR:US $ 115.78M 10.72M
Pacira Pharmaceuticals PCRX:US $ 253.33M 167.06M
Pfizer PFE:US $ 25920M 8234M
Redhill Biopharma RDHL:US $ 31.65M 4.22M
Revance Therapeutics RVNC:US $ 60.96M 2.69M
Teva Pharmaceutical TEVA:IT 13.16B 1.06B